April 15, 2016 Conference


PM Practical Application of Clinical Trials

Professional Practice Gaps:

Using feedback from NEOS members and discussion by the Program Committee, new treatments for wet and dry AMD was identified as a significant professional practice gap in our membership.

Program Objectives:

The content and format of this educational activity has been specifically designed to fill the identified practice gaps in our membership's current and potential scope of professional activities in a way that focuses on education, while managing commercial support and maintaining independence from promotional activities and commercial proprietary interests. This program seeks to:

1) Increase the competence of the audience in the areas of medical retina.
2) Improve the performance of the audience in clinical practice.
3) Improve outcomes in the area of patient care.

 


Safety of anti-VEGF injections
Andrew Lam


Innovative Approaches to Dry AMD: Past, Present & Future
Jeffrey Heier


The 1st Joan Miller Lecture— Pathophysiology of Retinal Vein Occlusion (RVO)-- Revelations of the anti-VEGF Trials.
David Brown


Advances in Retinal Imaging
Nadia Waheed


The Eye Can Handle Injections: Can The Patient?
Brad J. Baker


Management of Vitreomacular Traction Syndrome
Andre Witkin


Advances in the Treatment of Neovascular Age-Related Macular Degeneration
Fina C. Barouch


New Insights from DME Clinical Trials
David Brown


Treatment of Symptomatic Vitreous Floaters
Nauman A. Chaudhry


Intracameral antibiotics use in cataract surgery for postoperative endophthalmitis prophylaxis
Z. Katie Luo


A.M. Session Update on Systemic Disease

Professional Practice Gaps:

Using feedback from NEOS members and discussion by the Program Committee, updated knowledge on identification and management of medical disorders common in our patient population  was identified as a significant professional practice gap in our membership.

Program Objectives:

The content and format of this educational activity has been specifically designed to fill the identified practice gap in our membership's current and potential scope of professional activities in a way that focuses on education, while managing commercial support and maintaining independence from promotional activities and commercial proprietary interests. This program seeks to:

1) Increase the knowledge of the audience in the areas of: type II diabetes, osteoporosis, gene therapy, atrial fibrillation, dementia, cancer survivorship, and allergic disorders.
2) Improve the performance of clinical practice and risk management by updating common knowledge in the field of internal medicine.
3) Improve outcomes in the area of patient care by fostering a more complete appreciation of medical co-morbidities common in our patient base.

 


Osteoporosis Update: Advances in Fracture Risk Assessment and Treatment
Linda Jaffe


Cytokines in skin
Abrar Qureshi


Technology Innovations in the Treatment of Diabetes
Anne Peters


Atrial Fibrillation in 2016
Sarah Tsiaras


Infectious Diseases Today, Tomorrow, On Earth and Beyond
Leonard Mermel


Childhood Cancer Survivorship
Lisa Diller


ALZHEIMER’S DISEASE: CHARTING A PATH TO 2025
Steven Salloway


AN INTRODUCTION TO GENE THERAPY
Phil Reilly


New Paradigms for the Treatment of T2DM - Parts I and 2
Anne Peters